Key Takeaways
- An ASPE report released before President Trump took office found that beneficiaries could save $7bn on prescription drugs thanks to the new Medicare Part D spending cap.
- Each enrollee is expected to save about $600 annually, but those who do not receive the low-income subsidy would save more.
- Patients with CF, multiple myeloma or other major health conditions and not LIS eligible also could see substantial savings on drug costs in 2025.
The Inflation Reduction Act (IRA)’s $2,000 Part D spending cap, which took effect on 1 January, is projected to help more than 11 million Medicare beneficiaries save $7bn on prescription...
The out-of-pocket (OOP) threshold for Part D catastrophic coverage was capped at $2,000 beginning 1 January, down from $8,000, inclusive of manufacturer discounts on brand-name drugs. As a prelude to...